All In Biotech

Free tool

FAERS Monitor: Cimduo

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022141 or its brand name (Cimduo, Lamivudine, Tenofovir Disoproxil Fumarate). Reports on generic versions are filed under their own applications.

Reports

42

Serious

37

88% of reports

Hospitalization

5

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • foetal exposure during pregnancy12
  • maternal exposure during pregnancy10
  • abortion spontaneous6
  • anhedonia5
  • anxiety5
  • emotional distress5
  • pain5
  • premature baby4
  • depression3
  • exposure during pregnancy3
  • osteoporosis3
  • premature delivery3
  • subchorionic haematoma3
  • abortion induced2
  • acute kidney injury2

Reports by year received

View as table
YearReports
20121
20162
20171
20185
201916
202012
20212
20223

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,117 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
subchorionic haematomaSignal38692.92891.917,797
abortion induced2106.427.5117
anhedoniaSignal595.341.9377
premature deliverySignal394.431.7192
abortion spontaneousSignal675.035.8368
foetal exposure during pregnancySignal1273.945.8795
premature babySignal466.626.2197
maternal exposure during pregnancySignal1056.232.7490
osteoporosisSignal336.512.371
exposure during pregnancySignal324.28.146
emotional distressSignal520.79.175
anxietySignal58.83.928
depressionSignal36.62.29
acute kidney injury26.51.75
painSignal54.11.89

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.